Urah Transdermal Pte Ltd is a Singapore Drug Delivery Research and Development Company that has successfully introduced
lines of innovative transdermal products into the local and some overseas markets. Its success to date has been attributed to
a clear business strategy anchored on research-proven efficacy and customer-focused value delivery, underpinning an open
research paradigm of collaborating with university researchers as well as with user-based organizations, namely Nanyang
Technological University, A-star Biological Resource Centre, IMRE, Singapore Action Group of Elders (SAGE), Singapore Health
Promotion Board and Council for Third Age (C3A). Urah products are backed with technology patents in the US, Japan and
Singapore; and supported with published scientific reports in research journals.
Founders & Key Personnel
Dr. Jonathan Obaje (CEO) is the founder and inventor of most of Urah technologies such as the Proprietary
Obalin®Transdermal drug delivery System and the Biosurfactant process technology. He hold technology patents in the US,
Japan and Singapore, and has many research publications. Dr Obaje has worked in various research positions in
Universities and Institutes in Nigeria, England, Malaysia and Singapore. He has received a number of International
Academic Awards, among which are the American Oil Chemists' Society Honoured Student Award (2000) and the Lever Brothers
Scholarship Award for Outstanding Graduate Student Research in Surfactants and Detergents (1999). Dr Obaje is a
Chartered Scientist & Chartered Chemist (UK) and a professional member of the Royal Society of Chemistry.
Mr. Inderjit Singh is a prominent Singapore entrepreneur who is on the advisory boards of many Singapore Government
and private entrepreneurial institutions. He was a Member of Singapore Parliament 1996-2015, and board member of many
Mr. Geoffrey Kung brings on board many years of International Business Management experience in IBM, ICL, Honeywell and a host of other start-up companies.
Mr. Louis Yen is a serial entrepreneur who has over 30 years of experience in International Business. He is
currently also the Director of Louis Yen Singapore Pte. Ltd and BS Microelectronics (S) Pte. Ltd
Professor Yasuhiro Sawada is an orthopedic surgeon with many years of clinical and research experiences across
international institutions such as the University of Tokyo Teaching Hospital, Columbia University Hospital and the
National University of Singapore. He is currently the Director of the Tokyo Rehabilitation Centre, Japan.
Mr William Pok had been CEO and Management Team for multiple MNC companies and currently also holds the position
of CEO at WAN Global Ventures Pte. Ltd.